Global Deep Brain Stimulation Devices Market by Application (Parkinson's Disease, Epilepsy, Essential Tremor, Dystonia, Obsessive Compulsive Disorder, and Others) and End User (Hospitals, Ambulatory Surgical Centers, Neurological Clinics, and Others): Opportunity Analysis and Industry Forecast, 2019–2026
The global deep brain stimulation monitoring market was valued at $881.9 million in 2018, and is projected to reach $2,802.6 million by 2026, registering a CAGR of 15.5%.Deep brain stimulation is an electrical process of stimulating, inhibiting, modifying, regulating, and altering the activity in the central, autonomous, or peripheral nervous system in the human body. Deep brain stimulation devices send electrical impulse to the spine region wherein these signals block the pain signals from reaching the brain. These devices deliver electrical stimulation to the patient’s brain, spinal cord, and peripheral nervous system. Deep brain stimulation monitoring devices are particularly used for the treatment of neurological disorders such as epilepsy, chronic pain, Parkinson’s disease, depression, and other diseases. Advancements in the neurological technologies is delivering relief to the patients affected by psychiatric and neurological disorders.
According to the data published by WHO, there are around 50 million cases of dementia across the globe among which 60–70% is Alzheimer’s and 10 million are added every year. Dementia is the fifth leading cause of death worldwide. Furthermore, the incidence rate for Parkinson’s disease is 4.5–19 per 100,000 population every year.
Rise in prevalence of lifestyle diseases such as depression and chronic pain, increase in number of neurological disorders, and investment for neurological R&D are the factors that drive the growth of the global deep brain stimulation devices market. Moreover, rise in demand for minimal invasive surgery, adoption of technologically advanced products, and surge in aging population also propels the growth of the market as they are more susceptible to neurological disorders, such as Epilepsy, Parkinson’s disease, Alzheimer’s disease, and chronic pain. The major barriers for the growth of the deep brain stimulation devices marketare side effects such as allergic reaction and tingling or prickling of the skin due to implantation of deep brain stimulation device into the body and increase in device cost. However, availability of other treatment options such as drug therapies and surgeries restrict the growth of the market.
The deep brain stimulation devices marketis classified on the basis of application, enduser, and region. Based on application, the market is classified into Parkinson's disease, epilepsy, essential tremor, dystonia, obsessive compulsive disorder, and others. On the basis of application, it is categorized into hospitals, ambulatory surgical centers, neurological clinics, and others. Based on region, it is studied across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major players operating in the deep brain stimulation devices marketincludeAbbott Laboratories, AlevaNeurotherapeutics SA, Boston Scientific Corporation, Functional Neuromodulation Ltd., Beijing PINS Medical Co., Ltd., Medtronic plc, NeuroPace Inc., Nevro Corporation, and Neuronetics Inc. The other companies operating in the market are Electro Medics, ElectroCore, Neuros Medical, ElectroCore LLC, NeuroMetrix, EnteroMedics Inc., Neuronetics Inc., and SPR Therapeutics.
KEY BENEFITS FOR STAKEHOLDERS
By Application
According to the data published by WHO, there are around 50 million cases of dementia across the globe among which 60–70% is Alzheimer’s and 10 million are added every year. Dementia is the fifth leading cause of death worldwide. Furthermore, the incidence rate for Parkinson’s disease is 4.5–19 per 100,000 population every year.
Rise in prevalence of lifestyle diseases such as depression and chronic pain, increase in number of neurological disorders, and investment for neurological R&D are the factors that drive the growth of the global deep brain stimulation devices market. Moreover, rise in demand for minimal invasive surgery, adoption of technologically advanced products, and surge in aging population also propels the growth of the market as they are more susceptible to neurological disorders, such as Epilepsy, Parkinson’s disease, Alzheimer’s disease, and chronic pain. The major barriers for the growth of the deep brain stimulation devices marketare side effects such as allergic reaction and tingling or prickling of the skin due to implantation of deep brain stimulation device into the body and increase in device cost. However, availability of other treatment options such as drug therapies and surgeries restrict the growth of the market.
The deep brain stimulation devices marketis classified on the basis of application, enduser, and region. Based on application, the market is classified into Parkinson's disease, epilepsy, essential tremor, dystonia, obsessive compulsive disorder, and others. On the basis of application, it is categorized into hospitals, ambulatory surgical centers, neurological clinics, and others. Based on region, it is studied across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major players operating in the deep brain stimulation devices marketincludeAbbott Laboratories, AlevaNeurotherapeutics SA, Boston Scientific Corporation, Functional Neuromodulation Ltd., Beijing PINS Medical Co., Ltd., Medtronic plc, NeuroPace Inc., Nevro Corporation, and Neuronetics Inc. The other companies operating in the market are Electro Medics, ElectroCore, Neuros Medical, ElectroCore LLC, NeuroMetrix, EnteroMedics Inc., Neuronetics Inc., and SPR Therapeutics.
KEY BENEFITS FOR STAKEHOLDERS
- The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
- Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
- The key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.
By Application
- Parkinson's Disease
- Epilepsy
- Essential Tremor
- Dystonia
- Obsessive Compulsive Disorder
- Others
- Hospitals
- Ambulatory Surgical Centers
- Neurological Clinics
- Others
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Rest of Europe
- Asia-Pacific
- Australia
- Japan
- India
- China
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Abbott Laboratories
- Aleva Neurotherapeutics SA
- Boston Scientific Corporation
- Functional Neuromodulation Ltd.
- Beijing PINS Medical Co., Ltd.
- Medtronic plc
- NeuroPace Inc.
- Nevro Corporation
- Neuronetics Inc.
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2.1. Top investment pockets
3.3. Key forces shaping deep brain monitoring industry/market
3.4. Drivers
3.4.1.1. Increase in prevalence of neurological disorders
3.4.1.2. Surge in neurological R&D
3.4.2. Restraints
3.4.2.1. Risks and side effects associated with deep brain stimulation
3.4.3. Opportunities
3.4.3.1. Alternative uses of deep brain stimulators
3.4.4. Impact Analyses
CHAPTER 4: DEEP BRAIN STIMULATION MONITORING DEVICES MARKET, BY APPLICATION
4.1. Overview
4.1.1. Market size and forecast
4.2. Parkinson's Disease
4.2.1. Market size and forecast, by region
4.2.2. Market analysis, by country
4.3. Epilepsy
4.3.1. Market size and forecast, by region
4.3.2. Market analysis, by country
4.4. Dystonia
4.4.1. Market size and forecast, by region
4.4.2. Market analysis, by country
4.5. Essential Tremor
4.5.1. Market size and forecast, by region
4.5.2. Market analysis, by country
4.6. Obsessive-compulsive Disorder
4.6.1. Market size and forecast, by region
4.6.2. Market analysis, by country
4.7. Others
4.7.1. Market size and forecast, by region
4.7.2. Market analysis, by country
CHAPTER 5: DEEP BRAIN STIMULATION MONITORING DEVICES MARKET, BY END USER
5.1. Overview
5.1.1. Market size and forecast
5.2. Hospitals
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Ambulatory Surgical Centers
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Neurological Clinics
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
5.5. Others
5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country
CHAPTER 6: DEEP BRAIN STIMULATION MONITORING DEVICES MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends and opportunities
6.2.2. Market size and forecast, by application
6.2.3. Market size and forecast, by end user
6.2.4. Market size and forecast, by country
6.2.4.1. U.S. market size and forecast, by application
6.2.4.2. U.S. market size and forecast, by end user
6.2.4.3. Canada market size and forecast, by application
6.2.4.4. Canada market size and forecast, by end user
6.2.4.5. Mexico market size and forecast, by application
6.2.4.6. Mexico market size and forecast, by end user
6.3. Europe
6.3.1. Key market trends and opportunities
6.3.2. Market size and forecast, by application
6.3.3. Market size and forecast, by end user
6.3.4. Market size and forecast, by country
6.3.4.1. Germany market size and forecast, by application
6.3.4.2. Germany market size and forecast, by end user
6.3.4.3. France market size and forecast, by application
6.3.4.4. France market size and forecast, by end user
6.3.4.5. UK market size and forecast, by application
6.3.4.6. UK market size and forecast, by end user
6.3.4.7. Italy market size and forecast, by application
6.3.4.8. Italy market size and forecast, by end user
6.3.4.10. Rest of Europe market size and forecast, by application
6.3.4.11. Rest of Europe market size and forecast, by end user
6.4. Asia-Pacific
6.4.1. Key market trends and opportunities
6.4.2. Market size and forecast, by application
6.4.3. Market size and forecast, by end user
6.4.4. Market size and forecast, by country
6.4.4.1. China market size and forecast, by application
6.4.4.2. China market size and forecast, by end user
6.4.4.3. Japan market size and forecast, by application
6.4.4.4. Japan market size and forecast, by end user
6.4.4.5. India market size and forecast, by application
6.4.4.6. India market size and forecast, by end user
6.4.4.7. Australia market size and forecast, by application
6.4.4.8. Australia market size and forecast, by end user
6.4.4.9. Rest of Asia-Pacific market size and forecast, by application
6.4.4.10. Rest of Asia-Pacific market size and forecast, by end user
6.5. LAMEA
6.5.1. Key market trends and opportunities
6.5.2. Market size and forecast, by application
6.5.3. Market size and forecast, by end user
6.5.4. Market size and forecast, by country
6.5.4.1. Brazil market size and forecast, by application
6.5.4.2. Brazil market size and forecast, by end user
6.5.4.3. Saudi market size and forecast, by application
6.5.4.4. Saudi Arabia market size and forecast, by end user
6.5.4.5. South Africa market size and forecast, by application
6.5.4.6. South Africa market size and forecast, by end user
6.5.4.7. Rest of LAMEA market size and forecast, by application
6.5.4.8. Rest of LAMEA market size and forecast, by end user
CHAPTER 7: COMPANY PROFILES
7.1. Abbott Laboratories
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments
7.2. Aleva Neurotherapeutics SA
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Key strategic moves and developments
7.3. Boston Scientific Corporation
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments
7.4. Medtronic Plc
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.5. NeuroPace Inc.
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Key strategic moves and developments
7.6. Nevro Corporation
7.6.1. Company overview
7.6.2. Nevro: Company Snapshot
7.6.3. Operating business segment
7.6.4. Product portfolio
7.6.5. Business performance
7.6.6. Key strategic moves and developments
7.7. Neuronetics Inc.
7.7.1. Company overview
7.7.2. Neuronetics: Company Snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments
7.8. Functional Neuromodulation Ltd
7.8.1. Company overview
7.8.2. Functional.: Company Snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.9. Beijing PINS Medical Co., Ltd
7.9.1. Company overview
7.9.2. Beijing.: Company Snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2.1. Top investment pockets
3.3. Key forces shaping deep brain monitoring industry/market
3.4. Drivers
3.4.1.1. Increase in prevalence of neurological disorders
3.4.1.2. Surge in neurological R&D
3.4.2. Restraints
3.4.2.1. Risks and side effects associated with deep brain stimulation
3.4.3. Opportunities
3.4.3.1. Alternative uses of deep brain stimulators
3.4.4. Impact Analyses
CHAPTER 4: DEEP BRAIN STIMULATION MONITORING DEVICES MARKET, BY APPLICATION
4.1. Overview
4.1.1. Market size and forecast
4.2. Parkinson's Disease
4.2.1. Market size and forecast, by region
4.2.2. Market analysis, by country
4.3. Epilepsy
4.3.1. Market size and forecast, by region
4.3.2. Market analysis, by country
4.4. Dystonia
4.4.1. Market size and forecast, by region
4.4.2. Market analysis, by country
4.5. Essential Tremor
4.5.1. Market size and forecast, by region
4.5.2. Market analysis, by country
4.6. Obsessive-compulsive Disorder
4.6.1. Market size and forecast, by region
4.6.2. Market analysis, by country
4.7. Others
4.7.1. Market size and forecast, by region
4.7.2. Market analysis, by country
CHAPTER 5: DEEP BRAIN STIMULATION MONITORING DEVICES MARKET, BY END USER
5.1. Overview
5.1.1. Market size and forecast
5.2. Hospitals
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Ambulatory Surgical Centers
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Neurological Clinics
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
5.5. Others
5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country
CHAPTER 6: DEEP BRAIN STIMULATION MONITORING DEVICES MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends and opportunities
6.2.2. Market size and forecast, by application
6.2.3. Market size and forecast, by end user
6.2.4. Market size and forecast, by country
6.2.4.1. U.S. market size and forecast, by application
6.2.4.2. U.S. market size and forecast, by end user
6.2.4.3. Canada market size and forecast, by application
6.2.4.4. Canada market size and forecast, by end user
6.2.4.5. Mexico market size and forecast, by application
6.2.4.6. Mexico market size and forecast, by end user
6.3. Europe
6.3.1. Key market trends and opportunities
6.3.2. Market size and forecast, by application
6.3.3. Market size and forecast, by end user
6.3.4. Market size and forecast, by country
6.3.4.1. Germany market size and forecast, by application
6.3.4.2. Germany market size and forecast, by end user
6.3.4.3. France market size and forecast, by application
6.3.4.4. France market size and forecast, by end user
6.3.4.5. UK market size and forecast, by application
6.3.4.6. UK market size and forecast, by end user
6.3.4.7. Italy market size and forecast, by application
6.3.4.8. Italy market size and forecast, by end user
6.3.4.10. Rest of Europe market size and forecast, by application
6.3.4.11. Rest of Europe market size and forecast, by end user
6.4. Asia-Pacific
6.4.1. Key market trends and opportunities
6.4.2. Market size and forecast, by application
6.4.3. Market size and forecast, by end user
6.4.4. Market size and forecast, by country
6.4.4.1. China market size and forecast, by application
6.4.4.2. China market size and forecast, by end user
6.4.4.3. Japan market size and forecast, by application
6.4.4.4. Japan market size and forecast, by end user
6.4.4.5. India market size and forecast, by application
6.4.4.6. India market size and forecast, by end user
6.4.4.7. Australia market size and forecast, by application
6.4.4.8. Australia market size and forecast, by end user
6.4.4.9. Rest of Asia-Pacific market size and forecast, by application
6.4.4.10. Rest of Asia-Pacific market size and forecast, by end user
6.5. LAMEA
6.5.1. Key market trends and opportunities
6.5.2. Market size and forecast, by application
6.5.3. Market size and forecast, by end user
6.5.4. Market size and forecast, by country
6.5.4.1. Brazil market size and forecast, by application
6.5.4.2. Brazil market size and forecast, by end user
6.5.4.3. Saudi market size and forecast, by application
6.5.4.4. Saudi Arabia market size and forecast, by end user
6.5.4.5. South Africa market size and forecast, by application
6.5.4.6. South Africa market size and forecast, by end user
6.5.4.7. Rest of LAMEA market size and forecast, by application
6.5.4.8. Rest of LAMEA market size and forecast, by end user
CHAPTER 7: COMPANY PROFILES
7.1. Abbott Laboratories
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments
7.2. Aleva Neurotherapeutics SA
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Key strategic moves and developments
7.3. Boston Scientific Corporation
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments
7.4. Medtronic Plc
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.5. NeuroPace Inc.
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Key strategic moves and developments
7.6. Nevro Corporation
7.6.1. Company overview
7.6.2. Nevro: Company Snapshot
7.6.3. Operating business segment
7.6.4. Product portfolio
7.6.5. Business performance
7.6.6. Key strategic moves and developments
7.7. Neuronetics Inc.
7.7.1. Company overview
7.7.2. Neuronetics: Company Snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments
7.8. Functional Neuromodulation Ltd
7.8.1. Company overview
7.8.2. Functional.: Company Snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.9. Beijing PINS Medical Co., Ltd
7.9.1. Company overview
7.9.2. Beijing.: Company Snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
LIST OF TABLES
TABLE 01. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 02. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR PARKINSON'S DISEASE, BY REGION, 2018–2026 ($MILLION)
TABLE 03. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR EPILEPSY, BY REGION, 2018–2026 ($MILLION)
TABLE 04. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR DYSTONIA, BY REGION, 2018–2026 ($MILLION)
TABLE 05. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR ESSENTIAL TREMOR, BY REGION, 2018–2026 ($MILLION)
TABLE 06. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR OBSESSIVE COMPULSIVE DISORDER, BY REGION, 2018–2026 ($MILLION)
TABLE 07. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR OTHERS, BY REGION, 2018–2026 ($MILLION)
TABLE 08. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 09. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET, FOR HOSPITALS, BY REGION, 2018–2026 ($MILLION)
TABLE 10. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2018–2026 ($MILLION)
TABLE 11. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR NEUROLOGICAL CLINICS, BY REGION, 2018–2026 ($MILLION)
TABLE 12. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR OTHERS, BY REGION, 2018–2026 ($MILLION)
TABLE 13. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY REGION, 2018-2026, ($MILLION)
TABLE 14. NORTH AMERICA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 15. NORTH AMERICA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 16. NORTH AMERICA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY COUNTRY, 2018-2026, ($MILLION)
TABLE 17. U.S. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 18. U.S. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 19. CANADA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 20. CANADA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 21. MEXICO DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 22. MEXICO DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 23. EUROPE DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 24. EUROPE DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 25. EUROPE DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY COUNTRY, 2018-2026, ($MILLION)
TABLE 26. GERMANY DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 27. GERMANY DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 28. FRANCE DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 29. FRANCE DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 30. UK DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 31. UK DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 32. ITALY DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 33. ITALY DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 34. REST OF EUROPE DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 35. REST OF EUROPE DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 36. ASIA-PACIFIC DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 37. ASIA-PACIFIC DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 38. ASIA-PACIFIC DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY COUNTRY, 2018-2026, ($MILLION)
TABLE 39. CHINA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 40. CHINA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 41. JAPAN DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 42. JAPAN DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 43. INDIA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 44. INDIA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 45. AUSTRALIA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 46. AUSTRALIA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 47. REST OF ASIA-PACIFIC DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 48. REST OF ASIA-PACIFIC DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 49. LAMEA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 50. LAMEA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 51. LAMEA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY COUNTRY, 2018-2026, ($MILLION)
TABLE 52. BRAZIL DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 53. BRAZIL DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 54. SAUDI ARABIA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 55. SAUDI ARABIA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 56. SOUTH AFRICA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 57. SOUTH AFRICA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 58. REST OF LAMEA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 59. REST OF LAMEA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 60. ABBOTT: COMPANY SNAPSHOT
TABLE 61. ABBOTT: OPERATING SEGMENTS
TABLE 62. ABBOTT: PRODUCT PORTFOLIO
TABLE 63. ALEVA: COMPANY SNAPSHOT
TABLE 64. ALEVA: OPERATING SEGMENT
TABLE 65. ALEVA: PRODUCT PORTFOLIO
TABLE 66. BOSTON: COMPANY SNAPSHOT
TABLE 67. BOSTON: OPERATING SEGMENTS
TABLE 68. BOSTON: PRODUCT PORTFOLIO
TABLE 69. MEDTRONIC: COMPANY SNAPSHOT
TABLE 70. MEDTRONIC: OPERATING SEGMENTS
TABLE 71. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 72. NEUROPACE.: COMPANY SNAPSHOT
TABLE 73. NEUROPACE: OPERATING SEGMENTS
TABLE 74. NEUROPACE: PRODUCT PORTFOLIO
TABLE 75. NEVRO.: OPERATING SEGMENTS
TABLE 76. NEVRO.: PRODUCT PORTFOLIO
TABLE 77. NEURONETICS: OPERATING SEGMENT
TABLE 78. NEURONETICS: PRODUCT PORTFOLIO
TABLE 79. FUNCTIONAL.: OPERATING SEGMENT
TABLE 80. FUNCTIONAL.: PRODUCT PORTFOLIO
TABLE 81. BEIJING.: OPERATING SEGMENT
TABLE 82. BEIJING.: PRODUCT PORTFOLIO
TABLE 01. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 02. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR PARKINSON'S DISEASE, BY REGION, 2018–2026 ($MILLION)
TABLE 03. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR EPILEPSY, BY REGION, 2018–2026 ($MILLION)
TABLE 04. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR DYSTONIA, BY REGION, 2018–2026 ($MILLION)
TABLE 05. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR ESSENTIAL TREMOR, BY REGION, 2018–2026 ($MILLION)
TABLE 06. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR OBSESSIVE COMPULSIVE DISORDER, BY REGION, 2018–2026 ($MILLION)
TABLE 07. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR OTHERS, BY REGION, 2018–2026 ($MILLION)
TABLE 08. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 09. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET, FOR HOSPITALS, BY REGION, 2018–2026 ($MILLION)
TABLE 10. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2018–2026 ($MILLION)
TABLE 11. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR NEUROLOGICAL CLINICS, BY REGION, 2018–2026 ($MILLION)
TABLE 12. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR OTHERS, BY REGION, 2018–2026 ($MILLION)
TABLE 13. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY REGION, 2018-2026, ($MILLION)
TABLE 14. NORTH AMERICA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 15. NORTH AMERICA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 16. NORTH AMERICA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY COUNTRY, 2018-2026, ($MILLION)
TABLE 17. U.S. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 18. U.S. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 19. CANADA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 20. CANADA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 21. MEXICO DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 22. MEXICO DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 23. EUROPE DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 24. EUROPE DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 25. EUROPE DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY COUNTRY, 2018-2026, ($MILLION)
TABLE 26. GERMANY DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 27. GERMANY DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 28. FRANCE DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 29. FRANCE DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 30. UK DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 31. UK DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 32. ITALY DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 33. ITALY DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 34. REST OF EUROPE DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 35. REST OF EUROPE DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 36. ASIA-PACIFIC DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 37. ASIA-PACIFIC DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 38. ASIA-PACIFIC DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY COUNTRY, 2018-2026, ($MILLION)
TABLE 39. CHINA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 40. CHINA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 41. JAPAN DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 42. JAPAN DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 43. INDIA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 44. INDIA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 45. AUSTRALIA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 46. AUSTRALIA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 47. REST OF ASIA-PACIFIC DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 48. REST OF ASIA-PACIFIC DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 49. LAMEA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 50. LAMEA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 51. LAMEA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY COUNTRY, 2018-2026, ($MILLION)
TABLE 52. BRAZIL DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 53. BRAZIL DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 54. SAUDI ARABIA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 55. SAUDI ARABIA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 56. SOUTH AFRICA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 57. SOUTH AFRICA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 58. REST OF LAMEA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 59. REST OF LAMEA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)
TABLE 60. ABBOTT: COMPANY SNAPSHOT
TABLE 61. ABBOTT: OPERATING SEGMENTS
TABLE 62. ABBOTT: PRODUCT PORTFOLIO
TABLE 63. ALEVA: COMPANY SNAPSHOT
TABLE 64. ALEVA: OPERATING SEGMENT
TABLE 65. ALEVA: PRODUCT PORTFOLIO
TABLE 66. BOSTON: COMPANY SNAPSHOT
TABLE 67. BOSTON: OPERATING SEGMENTS
TABLE 68. BOSTON: PRODUCT PORTFOLIO
TABLE 69. MEDTRONIC: COMPANY SNAPSHOT
TABLE 70. MEDTRONIC: OPERATING SEGMENTS
TABLE 71. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 72. NEUROPACE.: COMPANY SNAPSHOT
TABLE 73. NEUROPACE: OPERATING SEGMENTS
TABLE 74. NEUROPACE: PRODUCT PORTFOLIO
TABLE 75. NEVRO.: OPERATING SEGMENTS
TABLE 76. NEVRO.: PRODUCT PORTFOLIO
TABLE 77. NEURONETICS: OPERATING SEGMENT
TABLE 78. NEURONETICS: PRODUCT PORTFOLIO
TABLE 79. FUNCTIONAL.: OPERATING SEGMENT
TABLE 80. FUNCTIONAL.: PRODUCT PORTFOLIO
TABLE 81. BEIJING.: OPERATING SEGMENT
TABLE 82. BEIJING.: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. MODERATE BARGAINING POWER OF SUPPLIER
FIGURE 04. MODERATE BARGAINING POWER OF BUYERS
FIGURE 05. LOW THREAT OF SUBSTITUTES
FIGURE 06. HIGH INTENSITY OF RIVALRY
FIGURE 07. LOW THREAT OF NEW ENTRANT
FIGURE 08. IMPACT ANALYSES, DEEP BRAIN MONITORING MARKET
FIGURE 09. COMPARATIVE ANALYSIS OF DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR PARKINSON'S DISEASE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 10. COMPARATIVE ANALYSIS OF DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR EPILEPSY, BY COUNTRY, 2018 & 2026 (%)
FIGURE 11. COMPARATIVE ANALYSIS OF DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR DYSTONIA, BY COUNTRY, 2018 & 2026 (%)
FIGURE 12. COMPARATIVE ANALYSIS OF DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR ESSENTIAL TREMOR, BY COUNTRY, 2018 & 2026 (%)
FIGURE 13. COMPARATIVE ANALYSIS OF DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR OBSESSIVE COMPULSIVE DISORDER, BY COUNTRY, 2018 & 2026 (%)
FIGURE 14. COMPARATIVE ANALYSIS OF DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR OTHERS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 15. COMPARATIVE ANALYSIS OF DEEP BRAIN STIMULATION MONITORING DEVICES MARKET, FOR HOSPITALS BY COUNTRY, 2018 & 2026 (%)
FIGURE 16. COMPARATIVE ANALYSIS OF DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 17. COMPARATIVE ANALYSIS OF DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR NEUROLOGICAL CLINICS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 18. COMPARATIVE ANALYSIS OF DEEP BRAIN STIMULATION MARKET FOR OTHERS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 19. ABBOTT: NET SALES, 2016–2018 ($MILLION)
FIGURE 20. ABBOTT: REVENUE SHARE BY SEGMENT, 2018(%)
FIGURE 21. ABBOTT: REVENUE SHARE BY REGION, 2018(%)
FIGURE 22. BOSTON: NET SALES, 2016–2018 ($MILLION)
FIGURE 23. BOSTON: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 24. BOSTON: REVENUE SHARE BY REGION, BY 2018%
FIGURE 25. MEDTRONIC: NET SALES, 2016–2018 ($MILLION)
FIGURE 26. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 27. MEDTRONIC: REVENUE SHARE BY REGION, 2018(%)
FIGURE 28. NEVRO: NET SALES, 2016–2018 ($MILLION)
FIGURE 29. NEVRO: REVENUE SHARE BY REGION,2018 %
FIGURE 30. NEURONETICS: NET SALES, 2016–2018 ($MILLION)
FIGURE 31. NEURONETICS: REVENUE SHARE BY REGION, 2018(%)
FIGURE 01. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. MODERATE BARGAINING POWER OF SUPPLIER
FIGURE 04. MODERATE BARGAINING POWER OF BUYERS
FIGURE 05. LOW THREAT OF SUBSTITUTES
FIGURE 06. HIGH INTENSITY OF RIVALRY
FIGURE 07. LOW THREAT OF NEW ENTRANT
FIGURE 08. IMPACT ANALYSES, DEEP BRAIN MONITORING MARKET
FIGURE 09. COMPARATIVE ANALYSIS OF DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR PARKINSON'S DISEASE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 10. COMPARATIVE ANALYSIS OF DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR EPILEPSY, BY COUNTRY, 2018 & 2026 (%)
FIGURE 11. COMPARATIVE ANALYSIS OF DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR DYSTONIA, BY COUNTRY, 2018 & 2026 (%)
FIGURE 12. COMPARATIVE ANALYSIS OF DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR ESSENTIAL TREMOR, BY COUNTRY, 2018 & 2026 (%)
FIGURE 13. COMPARATIVE ANALYSIS OF DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR OBSESSIVE COMPULSIVE DISORDER, BY COUNTRY, 2018 & 2026 (%)
FIGURE 14. COMPARATIVE ANALYSIS OF DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR OTHERS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 15. COMPARATIVE ANALYSIS OF DEEP BRAIN STIMULATION MONITORING DEVICES MARKET, FOR HOSPITALS BY COUNTRY, 2018 & 2026 (%)
FIGURE 16. COMPARATIVE ANALYSIS OF DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 17. COMPARATIVE ANALYSIS OF DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR NEUROLOGICAL CLINICS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 18. COMPARATIVE ANALYSIS OF DEEP BRAIN STIMULATION MARKET FOR OTHERS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 19. ABBOTT: NET SALES, 2016–2018 ($MILLION)
FIGURE 20. ABBOTT: REVENUE SHARE BY SEGMENT, 2018(%)
FIGURE 21. ABBOTT: REVENUE SHARE BY REGION, 2018(%)
FIGURE 22. BOSTON: NET SALES, 2016–2018 ($MILLION)
FIGURE 23. BOSTON: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 24. BOSTON: REVENUE SHARE BY REGION, BY 2018%
FIGURE 25. MEDTRONIC: NET SALES, 2016–2018 ($MILLION)
FIGURE 26. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 27. MEDTRONIC: REVENUE SHARE BY REGION, 2018(%)
FIGURE 28. NEVRO: NET SALES, 2016–2018 ($MILLION)
FIGURE 29. NEVRO: REVENUE SHARE BY REGION,2018 %
FIGURE 30. NEURONETICS: NET SALES, 2016–2018 ($MILLION)
FIGURE 31. NEURONETICS: REVENUE SHARE BY REGION, 2018(%)
